The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients
- PMID: 20035611
- DOI: 10.1089/sur.2007.080
The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients
Abstract
Background: Extended-interval dosing strategies have been developed to exploit the concentration-dependent bactericidal activity and time-dependent host toxicity associated with aminoglycoside the therapy. The ability of published extended-interval dosing nomograms to achieve optimal pharmacodynamic endpoints may be limited in certain critically ill surgical patients.
Methods: Review of pertinent English language literature. Presentation of descriptive, graded recommendations for extended-interval aminoglycoside dosing in critically ill surgical patients.
Results: Aminoglycoside dosing considerations in critically ill surgical patients should attempt to maximize the bacterial and host pharmacodynamic attributes of these agents. Empirically, extended-interval aminoglycoside doses proposed by published nomograms are reasonable for most patients; however, because of clinically meaningful variations in aminoglycoside pharmacokinetics, routine use of published extended-interval aminoglycoside dosing nomograms to determine an appropriate dosage interval is discouraged in many critically ill surgical patients. Critically ill surgical patients receiving extended-interval aminoglycoside dosages should undergo individualized pharmacokinetic analysis to characterize efficiently and more effectively plasma concentration-to-bacterial minimum inhibitory concentration (MIC) relationships and determine an appropriate dosing interval, considering site and severity of infection, plasma clearance, and the apparent post-antibiotic effect.
Conclusions: The use of extended-interval aminoglycoside dosage regimens in critically ill surgical patients should be based on pharmacodynamic endpoints and patient-specific pharmacokinetic assessment.
Similar articles
-
Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.Pharmacotherapy. 2018 Dec;38(12):1229-1238. doi: 10.1002/phar.2193. Pharmacotherapy. 2018. PMID: 30403305 Review.
-
Pharmacological considerations for the proper clinical use of aminoglycosides.Drugs. 2011 Dec 3;71(17):2277-94. doi: 10.2165/11597020-000000000-00000. Drugs. 2011. PMID: 22085385 Review.
-
Experience with a once-daily dosing program of aminoglycosides in critically ill patients.Intensive Care Med. 2002 Jul;28(7):936-42. doi: 10.1007/s00134-002-1313-7. Epub 2002 May 30. Intensive Care Med. 2002. PMID: 12122533
-
Suboptimal aminoglycoside dosing in critically ill patients.Ther Drug Monit. 2008 Dec;30(6):674-81. doi: 10.1097/FTD.0b013e31818b6b2f. Ther Drug Monit. 2008. PMID: 19057371
-
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.Int J Antimicrob Agents. 2010 Feb;35(2):156-63. doi: 10.1016/j.ijantimicag.2009.10.008. Epub 2009 Dec 16. Int J Antimicrob Agents. 2010. PMID: 20018492
Cited by
-
How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?BMC Infect Dis. 2014 Nov 28;14:288. doi: 10.1186/1471-2334-14-288. BMC Infect Dis. 2014. PMID: 25430961 Free PMC article. Review.
-
Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients.Antimicrob Agents Chemother. 2011 Sep;55(9):4006-11. doi: 10.1128/AAC.00174-11. Epub 2011 Jun 13. Antimicrob Agents Chemother. 2011. PMID: 21670189 Free PMC article.
-
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.World J Emerg Surg. 2011 Jan 13;6:2. doi: 10.1186/1749-7922-6-2. World J Emerg Surg. 2011. PMID: 21232143 Free PMC article.
-
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.Infection. 2016 Jun;44(3):395-439. doi: 10.1007/s15010-016-0885-z. Infection. 2016. PMID: 27066980 Free PMC article.
-
2013 WSES guidelines for management of intra-abdominal infections.World J Emerg Surg. 2013 Jan 8;8(1):3. doi: 10.1186/1749-7922-8-3. World J Emerg Surg. 2013. PMID: 23294512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical